Granisetron

Granisetron is a medicine used to help prevent nausea and vomiting, especially when someone is getting chemotherapy. It works by blocking a certain type of nerve signal that causes these side effects. It's often given as a shot or a pill to take before or during treatment.

Brand names:Kytril, Sancuso
Medication

What people taking Granisetron report

Every report comes from a Lived member, sent anonymously.

Have you tried Granisetron for Nausea?

NameHow it went

About Granisetron

What It's For

Granisetron is a prescription anti-nausea medicine used to prevent the nausea and vomiting that cancer treatment can cause. It is approved for chemotherapy that is likely to trigger vomiting (sometimes called emetogenic chemotherapy), including high-dose cisplatin (a chemotherapy drug known for causing severe vomiting), and the tablets are also approved for radiation that commonly causes nausea, such as total body irradiation or radiation to the abdomen. The injection has a separate use in adults: preventing or treating nausea and vomiting after surgery. It comes as generic tablets, an oral liquid, an injection given into a vein, and a skin patch sold as Sancuso. Sancuso is approved for adults receiving moderately or highly emetogenic chemotherapy over as many as five days in a row. The original brand, Kytril, is no longer sold in the US, and an extended-release injection called Sustol has also been discontinued. Granisetron belongs to a family of medicines called 5-HT3 receptor antagonists, which block one type of serotonin receptor (5-HT is the chemical name for serotonin). For chemotherapy with a meaningful risk of vomiting, it is usually one part of a planned combination rather than the only anti-nausea drug.

How It Works

Many chemotherapy drugs irritate the lining of the gut. Cells in that lining respond by releasing serotonin, a chemical messenger. The serotonin activates receptors known as 5-HT3 receptors on the vagus nerve, which carries signals from the gut to the brain, and on similar receptors in the part of the brainstem that triggers vomiting. That signal is a major driver of the nausea and vomiting that follow treatment. Granisetron blocks 5-HT3 receptors, so the serotonin released in the gut has much less effect on these vomiting pathways. This is why it works best when it is already in place before treatment begins. It does not speed up the stomach or bowel, and it can slow movement through the large bowel, which helps explain why constipation is a common side effect.

Dosage & Administration

How granisetron is given depends on the form. Tablets are taken up to an hour before chemotherapy, either as a single daily dose or split into two doses 12 hours apart, and only on the days chemotherapy is given; continuing them on days without chemotherapy has not been shown to help. For radiation, the tablets are taken within an hour of the session, as the care team directs. The injection is given into a vein by the care team within 30 minutes before chemotherapy, or around surgery, either before anesthesia starts or near its end. The Sancuso patch is applied once to clean, healthy skin on the upper outer arm 24 to 48 hours before chemotherapy. It stays on until at least 24 hours after the last chemotherapy dose and can be worn for up to 7 days. Only one patch is worn at a time, and it should not be cut. Heating pads or heat lamps over the patch can increase how much medicine is absorbed, so avoid them. The skin under the patch can react to sunlight, so keep it covered with clothing while wearing the patch and for 10 days after removing it. Do not use another granisetron product while wearing the patch. Afterward, fold it sticky side together and throw it away where children and pets cannot reach it. No dose change is recommended for older adults or for people with kidney or liver problems. The tablets have not been established as safe and effective for children, while the injection is used for chemotherapy-related nausea in children 2 years and older.

Side Effects

Headache and constipation are the most common side effects. In tablet studies, about one in five people reported a headache, compared with about one in eight on a placebo. Some people also notice weakness or tiredness, diarrhea, stomach discomfort, dizziness or trouble sleeping, although some of these overlap with the effects of chemotherapy itself. With the patch, constipation is the most common effect, and mild redness or irritation where the patch sits can occur. Remove the patch and tell the care team if the skin reaction is severe or a rash spreads beyond that area. Because granisetron can mask a developing bowel blockage, contact the care team right away if constipation comes with a swollen belly, worsening abdominal pain or no bowel movements at all, especially after abdominal surgery. Serious allergic reactions are rare. Trouble breathing, widespread hives or feeling faint after a dose needs emergency care.

Interactions & Warnings

The most important interaction risk is serotonin syndrome, a rare but potentially life-threatening reaction caused by too much serotonin activity. Most reported cases involved granisetron or a related anti-nausea drug combined with other medicines that raise serotonin, such as SSRI or SNRI antidepressants, MAO inhibitors (an older antidepressant group), mirtazapine (an antidepressant), lithium (a mood stabilizer), migraine medicines that act on serotonin, fentanyl and tramadol (opioid pain medicines), or methylene blue given into a vein (a medicine approved to treat methemoglobinemia, a rare blood disorder). Signs include agitation, confusion or hallucinations, a fast heartbeat, sweating, flushing or fever, and tremor, muscle stiffness, twitching, loss of coordination or seizures. These need immediate medical attention. Many cases have begun while people were still in a recovery room or infusion center, so report any of these signs to the nurses right away. Granisetron can also lengthen the QT interval, a measurement on an electrocardiogram (ECG) that reflects how long the heart takes to reset between beats. A longer QT can lead to an abnormal heart rhythm. The risk matters most for people who already have a heart rhythm problem or heart disease, are receiving chemotherapy that can affect the heart, have low potassium or magnesium, or take other medicines that prolong the QT interval. Tell the care team about any previous allergic reaction to granisetron or to another anti-nausea medicine in the same 5-HT3 family, since that raises the chance of reacting to granisetron. Animal studies have not shown harm in pregnancy, but there are no adequate studies in pregnant people, so anyone pregnant or planning pregnancy should discuss whether the benefit is clearly needed.

What to Expect

Granisetron is used around each treatment rather than taken continuously. For most chemotherapy, the care team chooses the anti-nausea plan based on how likely the specific regimen is to cause vomiting. For moderate-risk chemotherapy, guidelines generally pair a 5-HT3 blocker such as granisetron with a steroid, dexamethasone. For the highest-risk regimens, they add further medicines, such as an NK1 receptor blocker (for example, aprepitant) and olanzapine. Guideline reviews have not found major differences in effectiveness among the medicines in granisetron's family, so the choice often comes down to form, schedule, cost and what the rest of the regimen includes. Many people have less nausea and vomiting than they would without it, but prevention is not always complete. If nausea or vomiting breaks through, or appears days after treatment, telling the care team allows them to add a rescue medicine or change the plan for the next cycle. Since constipation is common and chemotherapy and opioid pain medicines can add to it, it helps to agree on a bowel plan early. The patch can suit people who have trouble swallowing pills or whose chemotherapy runs over several days, at the cost of the heat and sunlight precautions.

Questions to Ask Your Doctor

  1. 1.How likely is my chemotherapy or radiation to cause nausea, and which medicines will be combined with granisetron in my plan?
  2. 2.Would the tablets, an injection or the patch make the most sense for my treatment schedule?
  3. 3.Do any of my current medicines, especially antidepressants, migraine medicines or opioid pain relievers, raise my risk of serotonin syndrome or heart rhythm problems with granisetron?
  4. 4.What should I take if nausea breaks through, or starts a few days after treatment?
  5. 5.How should I prevent and manage constipation during treatment, and when should I call about it?

Last reviewed • Oct 2026

Educational content, not medical advice.